But phentermine fills a legitimate role for people who need a short-term boost, cannot afford GLP-1 medications, or have specific medical situations where stimulant-based appetite suppression is preferable
Metabolic syndrome is typically diagnosed when an individual has three or more of the following five key components
However, those benefits come at a significant financial cost, with annual treatment expenses typically ranging from $12,000 to $16,000 per patient. GLP1 coverage is one of the most consequential benefit decisions employers will face in 2026
Those prescribed GLP-1 medications for weight management through NHS specialist services (typically individuals with BMI 35 kg/m or 30 kg/m with comorbidities, according to NICE criteria) may target a larger calorie deficit than those using these medications primarily for glycaemic control with modest weight management
Boost energy levels 45 % Track your progress What our members say Real stories, real results Join thousands who've transformed their health with Thinera
Stomach pain or bloating is generally mild and transient